ANJAC Health & Beauty is a French family-owned industrial Group specializing in the formulation, manufacturing, and filling of cosmetics, medical devices, drugs, and food supplements. Integrating what is now 17 companies with 17 R&D sites and 24 manufacturing sites across Europe and North America, ANJAC creates, develops, and manufactures raw materials to finished products.
With the acquisition of Health Chain Group (HCG), composed of sister companies PharmaLinea, Hermes Consilium, and ErgoPharma, ANJAC follows its broader strategy to strengthen its health and pharma activities, particularly by expanding its nutrition and innovative food ingredients offering. The goal is to bridge food and supplementation to provide unique health solutions, backed by clinical studies. The acquisition also enhances ANJAC’s commercial presence in high-potential markets across Central and Eastern Europe, as well as in Asia, the Middle East, and North America.
Founded in 2008, ANJAC Health & Beauty Group now has a consolidated workforce of over 3.300 and a 2025 turnover expected of nearly €800million, positioning it as a leading comprehensive R&D and production partner for pharmaceutical laboratories, beauty, and wellness brands.